Patents
US 12534527 B2: KIR3DL3 is an inhibitory receptor of the immune system and uses thereof
- Granted
- 2026-01-27
- Filed
- 2020-10-01 application 17753731
- Type
- Utility · 16 claims
- Elsewhere
- Google Patents ↗ · USPTO patent document ↗ · USPTO Patent Center record ↗
Abstract
Described herein are antibodies, immunogenic fragments and compositions thereof targeting the killer-cell immunoglobulin-like receptor protein KIR3DL3, as well as methods of using the same for the treatment of human diseases including cancer. In certain embodiments, the disclosure relates to an antibody or an immunogenic fragment thereof that specifically binds to KIR3DL3 protein, wherein the antibody or the immunogenic fragment thereof specifically binds to a KIR3DL3 epitope comprising the whole extracellular domain or a portion thereof.
Source: PTBLXML, file of 2026-01-27 (ipgb20260127.xml).
Assignees
| Assignee | Type | Place | Also on furp.org | Source |
|---|---|---|---|---|
| Albert Einstein College of Medicine 218 patents | US company or organization | Bronx, NY | ALBERT EINSTEIN COLLEGE OF MEDICINE State business registration EXACT high confidence: identical full name and state Albert Einstein College of Medicine College or university EXACT high confidence: identical full name and state ALBERT EINSTEIN COLLEGE OF MEDICINE Nonprofit EXACT high confidence: identical full name and state | PTBLXML, file of 2026-01-27 |
Inventors
| Inventor | Place | Patents | Person page | Source |
|---|---|---|---|---|
| Xingxing Zang | New York, NY | 13 | PTBLXML, file of 2026-01-27 | |
| Yao Wei | Larchmont, NY | PTBLXML, file of 2026-01-27 | ||
| Xiaoxin Ren | Bronx, NY | PTBLXML, file of 2026-01-27 | ||
| Scott Moerdler | New York, NY | PTBLXML, file of 2026-01-27 |
CPC categories
| Subclass | Category | First group | Source |
|---|---|---|---|
| C07K | Peptides | C07K16/2803 | PTBLXML, file of 2026-01-27 |
| A61K | Preparations for medical, dental or toiletry purposes | A61K39/3955 | PTBLXML, file of 2026-01-27 |
| A61P | Specific therapeutic activity of chemical compounds or medicinal preparations | A61P35/00 | PTBLXML, file of 2026-01-27 |
Cooperative Patent Classification, as currently assigned (one row per subclass).
Assignments and security interests
No recorded assignments or security interests on file for this patent.
USPTO bulk data: PatentsView granted patents, disambiguated (PVGPATDIS) for patents, assignees, inventors, places and CPC categories; the USPTO Patent Assignment Dataset (ECORSEXC) for assignments and security interests. Patents filed in the last 20 years. No claims or full text. Links to other records are by name (and state): EXACT means the identical full name and state; FUZZY means a looser name match, with the confidence shown.